BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+3.35%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$17.4B
AUM Growth
+$17.4B
(+0.42%)
Cap. Flow
-$153M
Cap. Flow
% of AUM
-0.88%
Top 10 Holdings %
Top 10 Hldgs %
90.2%
Holding
115
New
7
Increased
16
Reduced
13
Closed
14
Top Buys
| 1 |
Roivant Sciences
ROIV
|
$28.6M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$20.8M |
| 3 |
AbCellera Biologics
ABCL
|
$19.8M |
| 4 |
Denali Therapeutics
DNLI
|
$17.3M |
| 5 |
Immunovant
IMVT
|
$16.3M |
Top Sells
| 1 |
argenx
ARGX
|
$63.4M |
| 2 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$55.9M |
| 3 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$48.1M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
$28.7M |
| 5 |
AnaptysBio
ANAB
|
$12M |
Sector Composition
| 1 | Healthcare | 99.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nurix Therapeutics
NRIX
$723M
| $30.5M | 0.18% |
3,882,125
| – | – |
|
27
Biomea Fusion
BMEA
$114M
| $29M | 0.17% |
2,108,949
| – | – |
|
28
IDEAYA Biosciences
IDYA
$2.26B
| $28.7M | 0.17% |
1,062,123
| – | – |
|
29
Cerus
CERS
$251M
| $27.9M | 0.16% |
17,239,501
+1,171,943
| +7% | +$1.9M |
|
|
JBIO
30
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| $26.6M | 0.15% |
1,963,479
| – | – |
|
|
IGMS
31
DELISTED
IGM Biosciences
IGMS
| $26.4M | 0.15% |
3,157,764
+554
| +0% | +$4.63K |
|
32
Xenon Pharmaceuticals
XENE
$2.99B
| $25.7M | 0.15% |
751,639
| – | – |
|
33
Cabaletta Bio
CABA
$144M
| $24.3M | 0.14% |
1,594,000
| – | – |
|
34
Monte Rosa Therapeutics
GLUE
$309M
| $23.5M | 0.14% |
4,916,095
+1,892,144
| +63% | +$9.06M |
|
|
DBVT
35
DBV Technologies
DBVT
$249M
| $19.9M | 0.11% |
14,614,264
| – | – |
|
36
Krystal Biotech
KRYS
$4.35B
| $19.7M | 0.11% |
169,934
| – | – |
|
|
VERV
37
DELISTED
Verve Therapeutics
VERV
| $18.8M | 0.11% |
1,416,530
| – | – |
|
|
BCYC
38
Bicycle Therapeutics
BCYC
$492M
| $17M | 0.1% |
843,814
| – | – |
|
|
39
Immunovant
IMVT
$2.91B
| $16.3M | 0.09% |
+425,009
| New | +$16.3M |
|
40
Cogent Biosciences
COGT
$1.83B
| $12.6M | 0.07% |
1,292,966
+313,366
| +32% | +$3.06M |
|
41
Day One Biopharmaceuticals
DAWN
$766M
| $12.3M | 0.07% |
1,000,000
| – | – |
|
42
Prime Medicine
PRME
$595M
| $9.81M | 0.06% |
1,028,466
| – | – |
|
|
TSVT
43
DELISTED
2seventy bio
TSVT
| $9.79M | 0.06% |
2,497,526
| – | – |
|
44
Relay Therapeutics
RLAY
$709M
| $9.76M | 0.06% |
1,160,117
| – | – |
|
45
Pacific Biosciences
PACB
$378M
| $9.42M | 0.05% |
1,127,782
| – | – |
|
46
Insmed
INSM
$30.3B
| $8.66M | 0.05% |
343,000
| – | – |
|
|
ADAP
47
Adaptimmune Therapeutics
ADAP
$13.9M
| $8.56M | 0.05% |
10,969,282
| – | – |
|
48
Tango Therapeutics
TNGX
$745M
| $8.45M | 0.05% |
750,000
| – | – |
|
49
Heron Therapeutics
HRTX
$204M
| $8.38M | 0.05% |
8,131,678
| – | – |
|
50
Arvinas
ARVN
$580M
| $8.12M | 0.05% |
+413,481
| New | +$8.12M |
|